In vivo studies with glioblastoma xenograft mice models revealed that pharmacological blockage of H1R using antihistamines impeded the growth of glioblastoma, establishing a potential therapeutic target in the TME for glioblastoma [105]. This evidence concerns the gene HRH1 and glioblastoma.